Bangkok Genomics Innovation Public Company Limited
BKGI.BK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.43B
Close$
$0.56
76.1% downside
Current Fair Value
76.1% downsideOvervalued by 76.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.43 Billion |
|---|---|
| Enterprise Value | $1.23 Billion |
| Dividend Yield | $0.05 (2.10%) |
| Earnings per Share | $0.08 |
| Beta | 1.33 |
| Outstanding Shares | 600,000,000 |
Return
| Return on Equity | 16.29% |
|---|---|
| Return on Assets | 12.80% |
| Return on Invested Capital | 16.73% |
Valuation & Multiples
| P/E Ratio | 15.03 |
|---|---|
| PEG | 2.43 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.28 |
| Enterprise Value to EBIT | 12.07 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$83.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$0.02
Average shareholder expectationRevenue Estimate
$83.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bangkok Genomics Innovation Public Company Limited
37 employees
CEO: Saowalak Dansakul Bangkok Genomics Innovation Public Company Limited, trading as BKGI.BK, is a Thailand-based enterprise delivering a diverse array of clinical and genomic services. Their core genetic offerings include the NIFTY brand for non-invasive pre...